glp-1 digital health platforms startups What's next for innovation: A primer on the race reshaping pharma and chronic disease care Virtual GLP-1 startups: Pill mills

This information is subject to change as the rate review process continues

Wegovy is a weight loss drug formulated by Novo Nordisk that was approved by the U.S

10.1016/S0197-4580(03)00087-3 Neurobiol Aging

GLP-1 Agonists Among the GLP-1 Agonists are Liraglutide (Saxenda), Dulaglutide (Trulicity), Semaglutide (Wegovy), Exenatide extended release (Bydureon bcise) (weekly), and Exenatide (Byetta) (twice daily)

Botanicals and polyphenols offer plant-based solutions for GLP-1 production with a more indirect impact on gut health

Multiple randomized, sham-controlled trials and meta-analyses show increases in hair density and hair shaft diameter in androgenetic alopecia with home devices, with a favorable safety profile